NovaBridge Biosciences (NBP) Operating Expenses (2019 - 2025)

NovaBridge Biosciences (NBP) has 5 years of Operating Expenses data on file, last reported at -$72.9 million in Q4 2025.

• On a quarterly basis, Operating Expenses fell 445.21% year-over-year to -$72.9 million in Q4 2025; TTM through Dec 2025 was -$94.3 million, a 83.31% decrease from a year earlier, with the FY2025 full-year figure at -$94.3 million, down 83.31% from the prior year.
• Operating Expenses for Q4 2025 stood at -$72.9 million, down from -$9.0 million in the prior quarter.
• Over the last five years, Operating Expenses for NBP reached as high as -$5.3 million in Q1 2025 and fell as low as -$72.9 million in Q4 2025.
• Historically, Operating Expenses has averaged -$16.9 million across 3 years, with a median of -$11.6 million in 2023.
• On a YoY basis, Operating Expenses climbed as much as 58.49% in 2025 and fell as far as 445.21% in 2025.
• Year by year, Operating Expenses stood at -$10.9 million in 2023, then declined by 22.12% to -$13.4 million in 2024, then plunged by 445.21% to -$72.9 million in 2025.
• Per Business Quant data, the three most recent Operating Expenses figures were -$72.9 million in Q4 2025, -$9.0 million in Q3 2025, and -$7.1 million in Q2 2025.